DSD-T105
Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T105
21-hydroxylase deficiency caused by the CYP21A2 P30L variant (overlapping non-classic and simple virilizing phenotypes) with partial glucocorticoid deficiency.
Case fields and evidence
- Category
-
Congenital adrenal hyperplasia (CAH)
- Age
-
26 years (first visit September 2017).
- Sex
-
Female.
- Karyotype
-
46,XY
- Genetics
-
AMH, AMHR2
- Phenotypes
-
Cryptorchidism (HP:0000028)
- Diagnosis
-
21-hydroxylase deficiency caused by the CYP21A2 P30L variant (overlapping non-classic and simple virilizing phenotypes) with partial glucocorticoid deficiency.
- Follow-up
-
Hirsutism improved, menses became regular, androgens and progesterone decreased, ACTH normalized; cesarean delivery of a healthy male infant at 39 weeks with breastfeeding; hydrocortisone continued postpartum.
- General phenotype
-
Female phenotype, moderate hirsutism (Ferriman-Gallwey score 24), above-normal weight, no external genital abnormalities or salt-wasting manifestations.
- Imaging
-
Not reported in the original article.
- Laboratory findings
-
17OHP 102.3 ng/ml (NV 0.2–1.3), total testosterone 1.86 ng/ml (NV 0.2–0.75), DHEAS 3.12 µg/ml; FSH 5.45 mU/ml, LH 1.98 mU/ml, estradiol 426.1 pmol/L, progesterone 16.84 nmol/L. After stopping OCP: 17OHP 65.37 ng/ml, ACTH 87–107.2 pg/ml, morning cortisol 185.1 nmol/L. After 6 months of hydrocortisone: 17OHP 12 ng/ml, progesterone 2.17 nmol/L, ACTH 33.12 pg/ml.
- Management
-
Dexamethasone was discontinued; Diane-35 was switched to Yasmin plus spironolactone 50 mg twice daily; spironolactone was stopped due to dizziness. From 2021, hydrocortisone 20 mg/day in two divided doses, increased to 25–30 mg/day during pregnancy, intravenous stress doses at delivery, and tapered to 10 mg/day 2 weeks postpartum.
- Pathology
-
Not reported in the original article.
- Evidence level
-
See source
- Clinical history
-
See source
- External genital examination
-
See source
- Limitations
-
See source
Cite this resource
DSD Research Library | Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T105 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T105?version=v1.4.0